Table 1 Clinical and pathological characteristics of the patients
From: Comparative study of endometrioid borderline ovarian tumor with and without endometriosis
Characteristics | EAEBOT (n = 19) | Non-EAEBOT (n = 33) | P |
|---|---|---|---|
Age(years)(mean ± SD) | 39.9 ± 7.5 | 43.1 ± 13.3 | 0.280 |
Age ≥ 50 years | 1(5.3%) | 10(30.3%) | 0.040 |
Nulliparous | 9(47.4%) | 15(45.5%) | 0.894 |
Gravidity number > 2 | 4(21.1%) | 11(33.3%) | 0.405 |
Symptom | |||
Pelvic mass | 19(100.0%) | 28(84.8%) | 0.145 |
Vaginal bleeding | 2(10.5%) | 7(21.2%) | 0.458 |
Pain | 1(5.3%) | 5(15.2%) | 0.397 |
Torsion | 0(0.0%) | 2(6.1%) | 0.527 |
Distension | 1(5.3%) | 0(0.0%) | 0.365 |
Menopause | 0(0.0%) | 12(36.4%) | 0.002 |
CA125 > 35 U/ml | 15(78.9%) | 18(54.5%) | 0.091 |
CA125 ≥ 140 U/ml | 7(36.8%) | 8(24.2%) | 0.376 |
Maximal tumor diameter ≥ 10 cm | 3(15.8%) | 7(21.2%) | 1.000 |
Cyst rupture | 14(73.7%) | 24(72.7%) | 1.000 |
FIGO stage | 1.000 | ||
I | 18(94.7%) | 31(93.9%) | |
II,III,IV | 1(5.3%) | 2(6.1%) | |
Tumor side | 0.145 | ||
Unilateral | 19(100.0%) | 28(84.8%) | |
Bilateral | 0(0.0%) | 5(15.2%) | |
Endometrial pathology | |||
Endometrial cancer | 5(26.3%) | 6(18.2%) | 0.503 |
EIN | 2(10.5%) | 6(18.2%) | 0.694 |